Peripheral administration of a x-opioid receptor agonist nalfurafine inactivates gonadotropin-releasing hormone pulse generator activity in goats

被引:0
|
作者
Matsuda, Fuko [1 ]
Ito, Daisuke [2 ]
Wakabayashi, Yoshihiro [3 ]
Yamamura, Takashi [3 ]
Okamura, Hiroaki [3 ]
Ohkura, Satoshi [2 ]
机构
[1] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Theriogenol, Tokyo 1138657, Japan
[2] Nagoya Univ, Grad Sch Bioagr Sci, Lab Anim Prod Sci, Nagoya 4648601, Japan
[3] Natl Agr & Food Res Org NARO, Inst Livestock & Grassland Sci, Div Adv Feeding Technol Res, Livestock Reprod Grp, Ibaraki 3050901, Japan
基金
日本学术振兴会;
关键词
Dynorphin A; GnRH pulse generator; KNDy neurons; KOR; MUA; ARCUATE NUCLEUS; KISSPEPTIN NEURONS; NEUROKININ B; DYNORPHIN-A; KNDY CELLS; KAPPA; HYDROCHLORIDE; INVOLVEMENT; SUPPRESSION; PULSATILE;
D O I
10.1016/j.neulet.2024.137918
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurons co-expressing kisspeptin, neurokinin B, and dynorphin A (KNDy neurons), located in the arcuate nucleus (ARC) of the hypothalamus, are indicated to be the gonadotropin-releasing hormone (GnRH) pulse generator. Dynorphin A is reported to suppress GnRH pulse generator activity. Nalfurafine is a selective agonist of the x-opioid receptor (KOR), a receptor for dynorphin A, clinically used as an anti-pruritic drug. This study aimed to evaluate the effects of nalfurafine on GnRH pulse generator activity and luteinizing hormone (LH) pulses using female goats. Nalfurafine (0, 2, 4, 8, or 16 mu g/head) was intravenously injected into ovariectomized Shiba goats. The multiple unit activity (MUA) in the ARC area was recorded, and plasma LH concentrations were measured 2 and 48 h before and after injection, respectively. The MUA volley interval during 0-2 h after injection was significantly increased in the nalfurafine 8 and 16 mu g groups compared with the vehicle group. In 0-2 h after injection, the number of LH pulses was significantly decreased in the nalfurafine 8 and 16 mu g groups, and the mean and baseline LH were significantly decreased in all nalfurafine-treated groups (2, 4, 8, and 16 mu g) compared with the vehicle group. These results suggest that nalfurafine inhibits the activity of the GnRH pulse generator in the ARC, thus suppressing pulsatile LH secretion. Therefore, nalfurafine could be used as a reproductive inhibitor in mammals.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
    Han, Eun Jin
    Do Song, Ha
    Yang, Ji Hoon
    Park, So Young
    Kim, Sung Hoon
    Yoon, Hyun Koo
    Yim, Chang Hoon
    ENDOCRINOLOGY AND METABOLISM, 2013, 28 (03) : 221 - 225
  • [32] Myxedema Coma Following the Administration of Gonadotropin-releasing Hormone Agonist Complicated by Acute Pancreatitis
    Gocho, Naoki
    Aoki, Ema
    Okada, Chiho
    Hirashima, Takeshi
    INTERNAL MEDICINE, 2018, 57 (21) : 3117 - 3122
  • [33] Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist
    Yu, KJ
    Lai, CR
    Sheu, MH
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 96 (02): : 223 - 225
  • [34] Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest
    Matsushima, Takashi
    Akira, Shigeo
    Yoneyama, Koichi
    Takeshita, Toshiyuki
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (06) : 521 - 524
  • [35] Thyroid Dysfunction after Gonadotropin-Releasing Hormone Agonist Administration in Women with Thyroid Autoimmunity
    Marin, Loris
    Ambrosini, Guido
    Noventa, Marco
    Filippi, Flavia
    Ragazzi, Eugenio
    Dessole, Francesco
    Capobianco, Giampiero
    Andrisani, Alessandra
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022, 2022
  • [36] Effects of kisspeptin-10 on the electrophysiological manifestation of gonadotropin-releasing hormone pulse generator activity in the female rat
    Kinsey-Jones, James S.
    Li, Xiao Feng
    Luckman, Simon M.
    O'Byrne, Kevin T.
    ENDOCRINOLOGY, 2008, 149 (03) : 1004 - 1008
  • [37] DOPAMINERGIC REGULATION OF GONADOTROPIN-RELEASING HORMONE RECEPTOR ACTIVITY IN THE GOLDFISH PITUITARY
    DELEEUW, R
    HABIBI, HR
    NAHORNIAK, CS
    PETER, RE
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1989, 74 (02) : 270 - 270
  • [38] Dependence of agonist activation on an aromatic moiety in the DPLIY motif of the gonadotropin-releasing hormone receptor
    Arora, KK
    Cheng, ZY
    Catt, KJ
    MOLECULAR ENDOCRINOLOGY, 1996, 10 (08) : 979 - 986
  • [39] Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency
    Zimmer, Carrie A.
    Ehrmann, David A.
    Rosenfield, Robert L.
    FERTILITY AND STERILITY, 2010, 94 (07) : 2697 - 2702
  • [40] CLOSED INTRAVENOUS ADMINISTRATION OF GONADOTROPIN-RELEASING HORMONE - SAFETY OF EXTENDED PERIPHERAL INTRAVENOUS CATHETERIZATION
    HOPKINS, CC
    HALL, JE
    SANTORO, NF
    MARTIN, KA
    FILICORI, M
    CROWLEY, WF
    OBSTETRICS AND GYNECOLOGY, 1989, 74 (02): : 267 - 270